MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0012717
Anselm Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹30.74 Lakh
▼ 91% YoY
Net loss · FY 2023
₹25.26 Lakh
Net margin -82.2%
EBITDA · FY 2023
-₹6.52 Lakh
EBITDA margin -21.2%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.5 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Anselm Pharmaceuticals Private Limited
Data last updated:
Anselm Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74994MH2016PTC272897. Its GSTIN is 27AAOCA1644B1ZY (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Siddhi Sushil Parab and Rajshri Ramchandra Dhamankar.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Shop No. 21 & 22 Kris Korner Commercial Plaza Opposite Swastik, Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2023, the company reported a revenue of ₹30.74 Lakh, a decline of 91% compared to the previous year. For the same year it recorded a net loss of ₹25.26 Lakh (net margin -82.2%) and EBITDA of -₹6.52 Lakh (EBITDA margin -21.2%). Revenue has declined at a compounded annual rate (CAGR) of 49% over three years and 29% over five years.
As per MCA filings, the company has open charges of ₹1.5 Cr on record.
Anselm Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0012717). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anselmpharma.com.
Company details
CIN U74994MH2016PTC272897
Registration Number 272897
Incorporation Date 08 February 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0012717
Recognitions & Rankings of Anselm Pharmaceuticals
Contact details
Anselm Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is anselmpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShop No. 21 & 22 Kris Korner Commercial Plaza Opposite Swastik, Thane, Maharashtra, India – 400607
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Anselm Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anselm Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anselm Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Anselm Pharmaceuticals Private Limited, buy the company report.
Financials of Anselm Pharmaceuticals Private Limited
FY 2023 filings availableAnselm Pharmaceuticals Private Limited reported revenue of ₹30.74 Lakh (down 91% YoY) for FY 2023.
Revenue · FY 2023
₹30.74 Lakh ▼ 91%
Net loss · FY 2023
₹25.26 Lakh margin -82.2%
EBITDA · FY 2023
-₹6.52 Lakh margin -21.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 91%
3 years · compounded
▼ 49%
5 years · compounded
▼ 29%
EBITDA CAGR growth
1 year
▼ 183%
3 years · compounded
▼ 55%
5 years · compounded
▼ 102%
Revenue has declined at a compounded annual rate (CAGR) of 29% over five years, including a 91% fall in the latest year. EBITDA fell 183% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.52 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹25.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -21.2% | ||||
| Net Profit Margin | -82.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anselm Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anselm Pharmaceuticals Private Limited
Anselm Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Siddhi Sushil Parab | Additional Director | 21 Dec 2022 | 3 Years 10 Months | Current |
| Rajshri Ramchandra Dhamankar | Additional Director | 21 Dec 2022 | 3 Years 10 Months | Current |
Auditor
Anselm Pharmaceuticals Private Limited is audited by MILLIND MEHTA & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MILLIND MEHTA & CO | FY 2021 | 129664W |
Shareholding
The shareholding of Anselm Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Anselm Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.5 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Mar 2021 | 100438368 | Hdfc Bank Limited | ₹1.5 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Anselm Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anselm Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anselm Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCA1644B1ZY | Maharashtra | Active | 01 Jul 2017 |
| 29AAOCA1644B1ZU | Karnataka | Active | 02 Aug 2019 |
To see the full GST registrations and return filing status of Anselm Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anselm Pharmaceuticals Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Mamta Pramod Castelino ceased to be Director on 22 Dec 2022.
AGM
Anselm Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Anselm Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
Ceased
Mamta Pramod Castelino ceased to be Director.
Ceased
Pramod John Castelino ceased to be Director.
Appointed
Rajshri Ramchandra Dhamankar was appointed as Additional Director.
Appointed
Siddhi Sushil Parab was appointed as Additional Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 150.00 Lakh with Charge ID 100438368 was registered on 05 Mar 2021.
Incorporation
08 Feb 2016
Anselm Pharmaceuticals Private Limited was registered on 08 Feb 2016 with Roc Mumbai & aged 10 years 8 months as per MCA records.
Frequently asked questions
Anselm Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 February 2016 (10+ years old) and is registered under CIN U74994MH2016PTC272897.
Anselm Pharmaceuticals has 2 current directors:
- Siddhi Sushil Parab - Additional Director
- Rajshri Ramchandra Dhamankar - Additional Director
The latest financial statements of Anselm Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Anselm Pharmaceuticals is 27AAOCA1644B1ZY, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 29AAOCA1644B1ZU (Karnataka).
The CIN (Corporate Identification Number) of Anselm Pharmaceuticals is U74994MH2016PTC272897. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anselm Pharmaceuticals was incorporated on 08 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Mamta Pramod Castelino ceased to be Director on 22 Dec 2022. Pramod John Castelino ceased to be Director on 22 Dec 2022. Rajshri Ramchandra Dhamankar was appointed as Additional Director on 21 Dec 2022. Anselm Pharmaceuticals has 4 board changes on record in total.
Yes, Anselm Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0012717).
Anselm Pharmaceuticals can be reached through the website anselmpharma.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Anselm Pharmaceuticals is at Shop No. 21 & 22 Kris Korner Commercial Plaza Opposite Swastik, Thane, Maharashtra, India – 400607.